Squarepoint’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,503
| Closed | -$26.9K | – | 2793 |
|
|
2024
Q4 | $26.9K | Buy |
4,503
+3,021
| +204% | +$18.1K | ﹤0.01% | 2696 |
|
|
2024
Q3 | $14.5K | Sell |
1,482
-659
| -31% | -$6.43K | ﹤0.01% | 2489 |
|
|
2024
Q2 | $43.8K | Buy |
+2,141
| New | +$43.8K | ﹤0.01% | 2375 |
|
|
2024
Q1 | – | Sell |
-3,568
| Closed | -$168K | – | 2478 |
|
|
2023
Q4 | $168K | Buy |
+3,568
| New | +$168K | ﹤0.01% | 2190 |
|
|
2021
Q4 | – | Sell |
-590
| Closed | -$286K | – | 2546 |
|
|
2021
Q3 | $286K | Sell |
590
-1,369
| -70% | -$664K | ﹤0.01% | 1654 |
|
|
2021
Q2 | $911K | Buy |
+1,959
| New | +$911K | ﹤0.01% | 1237 |
|
|
2021
Q1 | – | Sell |
-648
| Closed | -$479K | – | 2593 |
|
|
2020
Q4 | $479K | Buy |
+648
| New | +$479K | ﹤0.01% | 1530 |
|
|
2020
Q2 | – | Sell |
-901
| Closed | -$322K | – | 2166 |
|
|
2020
Q1 | $322K | Sell |
901
-544
| -38% | -$194K | 0.01% | 1262 |
|
|
2019
Q4 | $338K | Sell |
1,445
-777
| -35% | -$182K | ﹤0.01% | 1916 |
|
|
2019
Q3 | $250K | Buy |
2,222
+212
| +11% | +$23.9K | ﹤0.01% | 1889 |
|
|
2019
Q2 | $352K | Buy |
+2,010
| New | +$352K | ﹤0.01% | 1801 |
|
|
2018
Q4 | – | Sell |
-1,156
| Closed | -$142K | – | 1937 |
|
|
2018
Q3 | $142K | Buy |
+1,156
| New | +$142K | ﹤0.01% | 1834 |
|